Researchers@EVMS
Toggle navigation
Browse
Home
Researchers
Research Areas
Capability Map
Publications
Departments
Clinical Trials
Student Opportunities
FAQ
CANCER IMMUNOLOGY RESEARCH
Journal
Overview
Identity
Other
View All
Overview
publication venue for
Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor- Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors br
. 10:932-946.
2022
Identity
International Standard Serial Number (ISSN)
2326-6066
Electronic International Standard Serial Number (EISSN)
2326-6074
Other
journal abbreviation
CANCER IMMUNOL RES
